Takuto Hideyama

1.2k total citations
38 papers, 913 citations indexed

About

Takuto Hideyama is a scholar working on Molecular Biology, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Takuto Hideyama has authored 38 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Neurology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Takuto Hideyama's work include RNA regulation and disease (16 papers), Amyotrophic Lateral Sclerosis Research (12 papers) and Viral Infections and Immunology Research (8 papers). Takuto Hideyama is often cited by papers focused on RNA regulation and disease (16 papers), Amyotrophic Lateral Sclerosis Research (12 papers) and Viral Infections and Immunology Research (8 papers). Takuto Hideyama collaborates with scholars based in Japan, United Kingdom and Germany. Takuto Hideyama's co-authors include Shin Kwak, Takenari Yamashita, Hitoshi Aizawa, Shoji Tsuji, Sayaka Teramoto, Hitoshi Takahashi, Akiyoshi Kakita, Takeshi Suzuki, Nobuhisa Iwata and Takashi Kimura and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Takuto Hideyama

37 papers receiving 905 citations

Peers

Takuto Hideyama
Takuto Hideyama
Citations per year, relative to Takuto Hideyama Takuto Hideyama (= 1×) peers Giulia Bisogni

Countries citing papers authored by Takuto Hideyama

Since Specialization
Citations

This map shows the geographic impact of Takuto Hideyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuto Hideyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuto Hideyama more than expected).

Fields of papers citing papers by Takuto Hideyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuto Hideyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuto Hideyama. The network helps show where Takuto Hideyama may publish in the future.

Co-authorship network of co-authors of Takuto Hideyama

This figure shows the co-authorship network connecting the top 25 collaborators of Takuto Hideyama. A scholar is included among the top collaborators of Takuto Hideyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuto Hideyama. Takuto Hideyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Haruhisa, Makiko Naito, Tomoko Saito, et al.. (2022). Prolyl Isomerase Pin1 Expression in the Spinal Motor Neurons of Patients With Sporadic Amyotrophic Lateral Sclerosis. Journal of Clinical Neurology. 18(4). 463–463. 4 indexed citations
2.
Mitsutake, Akihiko, Takashi Matsukawa, Tatsuya Sato, et al.. (2020). A Japanese family with primary familial brain calcification presenting with paroxysmal kinesigenic dyskinesia - A comprehensive mutational analysis-. Journal of the Neurological Sciences. 418. 117091–117091. 2 indexed citations
3.
Arakawa, Akira, Akihiko Mitsutake, Takuto Hideyama, et al.. (2020). A central nervous system metastasis of melanoma with stroke‐like onset of left‐lower quadrantanopsia. Journal of General and Family Medicine. 21(3). 77–79. 2 indexed citations
4.
Mitsutake, Akihiko, Tatsuya Sato, Fumiko Kusunoki Nakamoto, et al.. (2019). Tumefactive multiple sclerosis which initially presented with brainstem encephalitis with a long-term follow-up. Multiple Sclerosis and Related Disorders. 32. 23–26. 2 indexed citations
5.
Aizawa, Hitoshi, Takuto Hideyama, Takenari Yamashita, et al.. (2016). Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUSP525L mutation. Journal of Clinical Neuroscience. 32. 128–129. 35 indexed citations
6.
Yamashita, Takenari, Takuto Hideyama, Sayaka Teramoto, et al.. (2012). A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nature Communications. 3(1). 1307–1307. 136 indexed citations
7.
Hideyama, Takuto, et al.. (2012). Co-Occurrence of TDP-43 Mislocalization with Reduced Activity of an RNA Editing Enzyme, ADAR2, in Aged Mouse Motor Neurons. PLoS ONE. 7(8). e43469–e43469. 26 indexed citations
8.
Yamashita, Takenari, et al.. (2012). RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2. Neuroscience Research. 73(1). 42–48. 12 indexed citations
9.
Yamashita, Takenari, Takuto Hideyama, Sayaka Teramoto, & Shin Kwak. (2012). The abnormal processing of TDP-43 is not an upstream event of reduced ADAR2 activity in ALS motor neurons. Neuroscience Research. 73(2). 153–160. 14 indexed citations
10.
Hideyama, Takuto & Shin Kwak. (2011). When Does ALS Start? ADAR2?GluA2 Hypothesis for the Etiology of Sporadic ALS. Frontiers in Molecular Neuroscience. 4. 33–33. 38 indexed citations
11.
Hideyama, Takuto, Takenari Yamashita, Hitoshi Aizawa, et al.. (2011). Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Neurobiology of Disease. 45(3). 1121–1128. 152 indexed citations
12.
Hideyama, Takuto, Takenari Yamashita, Yoshinori Nishimoto, Takeshi Suzuki, & Shin Kwak. (2010). Novel Etiological and Therapeutic Strategies for Neurodiseases: RNA Editing Enzyme Abnormality in Sporadic Amyotrophic Lateral Sclerosis. Journal of Pharmacological Sciences. 113(1). 9–13. 8 indexed citations
13.
Kwak, Shin, Takuto Hideyama, Takenari Yamashita, & Hitoshi Aizawa. (2010). AMPA receptor-mediated neuronal death in sporadic ALS. Neuropathology. 30(2). 182–188. 70 indexed citations
14.
Aizawa, Hitoshi, Jun Sawada, Takuto Hideyama, et al.. (2010). TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Acta Neuropathologica. 120(1). 75–84. 98 indexed citations
15.
Hideyama, Takuto, Takenari Yamashita, Takeshi Suzuki, et al.. (2010). Induced Loss of ADAR2 Engenders Slow Death of Motor Neurons from Q/R Site-Unedited GluR2. Journal of Neuroscience. 30(36). 11917–11925. 133 indexed citations
16.
Nishimoto, Yoshinori, Takenari Yamashita, Takuto Hideyama, et al.. (2008). Determination of editors at the novel A-to-I editing positions. Neuroscience Research. 61(2). 201–206. 46 indexed citations
17.
Hideyama, Takuto, Hiroshi Tanaka, Yoshikazu Uesaka, Masanari Kunimoto, & Akiyoshi Miwa. (2008). A case of primary intraocular central nervous system lymphoma with high interleukin 10 level and positive cytology in cerebrospinal fluid. Rinsho Shinkeigaku. 48(6). 415–418. 3 indexed citations
18.
Hideyama, Takuto, Toshimitsu Momose, Jun Shimizu, Shoji Tsuji, & Shin Kwak. (2006). A Positron Emission Tomography Study on the Role of Nigral Lesions in Parkinsonism in Patients With Amyotrophic Lateral Sclerosis. Archives of Neurology. 63(12). 1719–1719. 19 indexed citations
19.
Kawahara, Yukio, Hui Sun, Kyoko Ito, et al.. (2005). Underediting of GluR2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA. Neuroscience Research. 54(1). 11–14. 50 indexed citations
20.
Hideyama, Takuto, et al.. (2005). [A 95-year-old female with autopsy-proven cerebral necrosis due to candidiasis who developed stroke-like manifestations].. PubMed. 45(3). 230–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026